CERo Therapeutics Holdings Inc CERO
$0.10 $1.69 (94.69%) 1D
Last Updated: Oct 30, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
CERO Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, CERo Therapeutics Holdings Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
CERo Therapeutics Holdings Inc. Stock Analysis CERO
United States Health Care Nano Cap CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. The company is headquartered in South San Francisco, California and currently employs 8 full-time employees. The company went IPO on 2021-10-06. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body’s full immune repertoire to achieve optimized cancer therapy. This novel cellular immunotherapy platform is designed to redirect patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating what the Company refers to as Chimeric Engulfment Receptor T cells (CER-T). Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand. The firm is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies.
CERo Therapeutics Holdings Inc (CERO) Chart
Financial Metrics & Statements of CERo Therapeutics Holdings Inc (CERO)
FAQ's for CERo Therapeutics Holdings Inc (CERO)
- As of August 2026, CERo Therapeutics Holdings Inc CERO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes CERo Therapeutics Holdings Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in CERo Therapeutics Holdings Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of CERo Therapeutics Holdings Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of CERo Therapeutics Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of CERo Therapeutics Holdings Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for CERo Therapeutics Holdings Inc (CERO)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
